Giovanna Lattanzi Selected Research

Laminopathies

1/2024	Desmin and Plectin Recruitment to the Nucleus and Nuclei Orientation Are Lost in Emery-Dreifuss Muscular Dystrophy Myoblasts Subjected to Mechanical Stimulation.
1/2023	Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson-Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies.
2/2022	The wide and growing range of lamin B-related diseases: from laminopathies to cancer.
1/2022	The role of prelamin A post-translational maturation in stress response and 53BP1 recruitment.
1/2020	Cytokine Profile in Striated Muscle Laminopathies: New Promising Biomarkers for Disease Prediction.
1/2020	Lamin A involvement in ageing processes.
2/2019	The Cutting Edge: The Role of mTOR Signaling in Laminopathies.
1/2019	Ankrd2 in Mechanotransduction and Oxidative Stress Response in Skeletal Muscle: New Cues for the Pathogenesis of Muscular Laminopathies.
1/2019	Statins and Histone Deacetylase Inhibitors Affect Lamin A/C - Histone Deacetylase 2 Interaction in Human Cells.
4/2018	Lamins and bone disorders: current understanding and perspectives.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanna Lattanzi Research Topics

Disease

30	Laminopathies 01/2024 - 01/2005
13	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 01/2024 - 04/2003
13	Progeria (Hutchinson Gilford Syndrome) 01/2023 - 09/2009
9	Lipodystrophy 11/2023 - 06/2005
8	Familial Partial Lipodystrophy (Dunnigan Syndrome) 11/2023 - 11/2003
6	Neoplasms (Cancer) 02/2022 - 05/2015
5	Inborn Genetic Diseases (Disease, Hereditary) 10/2023 - 01/2005
5	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 03/2002
4	Genomic Instability 12/2021 - 11/2019
4	Cardiomyopathies (Cardiomyopathy) 04/2021 - 06/2012
3	Ewing Sarcoma (Sarcoma, Ewing) 01/2022 - 07/2004
3	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 01/2020 - 12/2003
3	Muscular Dystrophies (Muscular Dystrophy) 10/2018 - 04/2011
3	Werner Syndrome (Werner's Syndrome) 07/2010 - 06/2005
2	Autosomal Emery-Dreifuss Muscular Dystrophy 01/2019 - 01/2017
2	Disease Progression 01/2019 - 06/2013
2	Bone Resorption 10/2015 - 09/2008
2	Rare Diseases (Rare Disease) 07/2011 - 09/2009
1	Cockayne Syndrome (Syndrome, Cockayne) 10/2023
1	UV-Sensitive Syndrome 10/2023
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 03/2022
1	Brain Diseases (Brain Disorder) 02/2022
1	Hypertrophy 01/2022
1	Carcinogenesis 01/2021
1	Kyphosis 01/2021
1	Inflammation (Inflammations) 01/2020
1	Atrial Fibrillation 11/2019
1	Melanoma (Melanoma, Malignant) 01/2018
1	Heart Failure 01/2018
1	Heart Diseases (Heart Disease) 01/2018
1	Ventricular Tachycardia 01/2018
1	Bradycardia 01/2018
1	Stroke (Strokes) 01/2018
1	Atherosclerosis 10/2015
1	Sarcoma (Soft Tissue Sarcoma) 05/2015
1	Rhabdomyosarcoma 05/2015
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 06/2013
1	Osteolysis 09/2008
1	Osteoporosis 09/2008
1	Infections 03/2008
1	Cytomegalovirus Infections (Inclusion Disease) 03/2008

Drug/Important Bio-Agent (IBA)

30	Lamin Type A (Lamin A)IBA 01/2024 - 04/2003
17	prelamin AIBA 01/2022 - 06/2005
12	Proteins (Proteins, Gene)FDA Link 10/2023 - 12/2003
11	LaminsIBA 02/2022 - 11/2003
5	HeterochromatinIBA 01/2020 - 01/2007
4	emerinIBA 01/2020 - 04/2003
4	ChromatinIBA 03/2016 - 10/2005
3	Lamin Type B (Lamin B)IBA 02/2022 - 03/2008
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 10/2011
2	DNA Transposable Elements (Element, IS)IBA 01/2020 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2018
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2020 - 04/2018
2	MTOR InhibitorsIBA 01/2019 - 11/2016
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 04/2011
2	Sirolimus (Rapamycin)FDA Link 11/2016 - 10/2015
2	PPAR gammaIBA 06/2005 - 03/2002
1	DesminIBA 01/2024
1	PlectinIBA 01/2024
1	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 11/2023
1	baricitinibIBA 01/2023
1	monoaminocarboxydihydroboraneIBA 01/2023
1	desmuslin (synemin)IBA 04/2021
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2020
1	TESIBA 01/2020
1	Interleukin-4 (Interleukin 4)IBA 01/2020
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020
1	CytokinesIBA 01/2020
1	Interleukin-8 (Interleukin 8)IBA 01/2020
1	ChemokinesIBA 01/2020
1	Karyopherins (Importin)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	AF 57IBA 11/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 02/2019
1	Protein Isoforms (Isoforms)IBA 01/2019
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 11/2018
1	Decitabine FDA Link 01/2018
1	AntigensIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	Therapeutic UsesIBA 11/2016
1	Small Interfering RNA (siRNA)IBA 03/2016
1	Histones (Histone)IBA 10/2015
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2015
1	MC1742IBA 05/2015
1	TubulinIBA 05/2015
1	MC2625IBA 05/2015
1	Histone Deacetylase InhibitorsIBA 05/2015
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 10/2011
1	Cysteine (L-Cysteine)FDA Link 10/2011
1	lamina-associated polypeptide 2IBA 04/2011
1	Nuclear Matrix-Associated ProteinsIBA 04/2011
1	Peptides (Polypeptides)IBA 04/2011
1	Protein PrecursorsIBA 07/2010
1	Nuclear Localization Signals (Nuclear Localization Signal)IBA 07/2008
1	Viral ProteinsIBA 03/2008

Therapy/Procedure

3	Heart Transplantation (Grafting, Heart) 03/2022 - 10/2013
3	Therapeutics 01/2019 - 02/2008
1	Cardiac Resynchronization Therapy 01/2018